Skip to main content
DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
68.74
+0.64 (0.94%)
At close: Mar 9, 2026, 4:00 PM EDT
68.90
+0.16 (0.23%)
After-hours: Mar 9, 2026, 6:35 PM EDT

DexCom Revenue

In the year 2025, DexCom had annual revenue of $4.66B with 15.60% growth. DexCom had revenue of $1.26B in the quarter ending December 31, 2025, with 13.12% growth.

Revenue (ttm)
$4.66B
Revenue Growth
+15.60%
P/S Ratio
5.67
Revenue / Employee
$420,000
Employees
11,100
Market Cap
26.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.66B629.00M15.60%
Dec 31, 20244.03B410.70M11.34%
Dec 31, 20233.62B712.50M24.49%
Dec 31, 20222.91B461.30M18.84%
Dec 31, 20212.45B521.80M27.08%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Koninklijke Philips 20.94B
GE HealthCare Technologies 20.63B
Zimmer Biomet Holdings 8.23B
Smith & Nephew 6.16B
Edwards Lifesciences 6.07B
STERIS 5.83B
Globus Medical 2.94B
Insulet 2.71B
Revenue Rankings

DXCM News

More News